SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹31 Cr | ₹27 Cr | ₹23 Cr | ₹14 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 15.64 | |
| Mar2025 | ₹27 Cr | 16.70 | |
| Mar2024 | ₹23 Cr | 69.30 | |
| Mar2023 | ₹14 Cr | 22.66 | |
| Mar2022 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹7,081.6 Cr | -3.5% | 12.2% | 33.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -3.5% |
12.2% |
33.5% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses